NDC 82988-101 Ice Blue Pain Alleviating Rub

View Dosage, Usage, Ingredients, Routes, UNII

Product Information

This product is EXCLUDED from the official NDC directory because the listing data was inactivated by the FDA.
NDC Product Code:
Proprietary Name:
Ice Blue Pain Alleviating Rub
Product Type: [3]
Labeler Code:
FDA Application Number: [6]
Marketing Category: [8]
OTC MONOGRAPH NOT FINAL - A product marketed pursuant to an Over-the-Counter (OTC) Drug Monograph that is not final.
Start Marketing Date: [9]
Listing Expiration Date: [11]
Exclude Flag: [12]
Code Navigator:

Code Structure Chart

Product Details

What is NDC 82988-101?

The NDC code 82988-101 is assigned by the FDA to the product Ice Blue Pain Alleviating Rub which is product labeled by Lemisol Corporation. The product's dosage form is . The product is distributed in 2 packages with assigned NDC codes 82988-101-08 226.7 g in 1 jar , 82988-101-16 453.5 g in 1 jar . This page includes all the important details about this product, including active and inactive ingredients, pharmagologic classes, product uses and characteristics, UNII information and RxNorm crosswalk.

What are the uses for Ice Blue Pain Alleviating Rub?

Uses provides temporary relief of minor aches and pains in muscles and joints associated with arthritis simple backache muscle strains sprains bruises cramps

Which are Ice Blue Pain Alleviating Rub UNII Codes?

The UNII codes for the active ingredients in this product are:

Which are Ice Blue Pain Alleviating Rub Inactive Ingredients UNII Codes?

The inactive ingredients are all the component of a medicinal product OTHER than the active ingredient(s). The acronym "UNII" stands for “Unique Ingredient Identifier” and is used to identify each inactive ingredient present in a product. The UNII codes for the inactive ingredients in this product are:

What is the NDC to RxNorm Crosswalk for Ice Blue Pain Alleviating Rub?

RxNorm is a normalized naming system for generic and branded drugs that assigns unique concept identifier(s) known as RxCUIs to NDC products.The NDC to RxNorm Crosswalk for this produdct indicates multiple concept unique identifiers (RXCUIs) are associated with this product:
  • RxCUI: 2624202 - camphor 0.3 % / menthol 2.5 % / methyl salicylate 2.2 % Topical Gel
  • RxCUI: 2624202 - camphor 0.003 MG/MG / menthol 0.025 MG/MG / methyl salicylate 0.022 MG/MG Topical Gel
  • RxCUI: 2624203 - camphor 3 % / menthol 5 % / methyl salicylate 8 % Topical Spray
  • RxCUI: 2624203 - camphor 30 MG/ML / menthol 50 MG/ML / methyl salicylate 80 MG/ML Topical Spray

* Please review the disclaimer below.

Product Footnotes

[5] What is the Labeler Name? - Name of Company corresponding to the labeler code segment of the Product NDC.

[6] What is the FDA Application Number? - This corresponds to the NDA, ANDA, or BLA number reported by the labeler for products which have the corresponding Marketing Category designated. If the designated Marketing Category is OTC Monograph Final or OTC Monograph Not Final, then the Application number will be the CFR citation corresponding to the appropriate Monograph (e.g. “part 341”). For unapproved drugs, this field will be null.

[8] What is the Marketing Category? - Product types are broken down into several potential Marketing Categories, such as NDA/ANDA/BLA, OTC Monograph, or Unapproved Drug. One and only one Marketing Category may be chosen for a product, not all marketing categories are available to all product types. Currently, only final marketed product categories are included. The complete list of codes and translations can be found at www.fda.gov/edrls under Structured Product Labeling Resources.

[9] What is the Start Marketing Date? - This is the date that the labeler indicates was the start of its marketing of the drug product.

[11] What is the Listing Expiration Date? - This is the date when the listing record will expire if not updated or certified by the product labeler.

[12] What is the NDC Exclude Flag? - This field indicates whether the product has been removed/excluded from the NDC Directory for failure to respond to FDA"s requests for correction to deficient or non-compliant submissions ("Y"), or because the listing certification is expired ("E"), or because the listing data was inactivated by FDA ("I"). Values = "Y", "N", "E", or "I".